CAPRICOR THERAPEUTICS INC - COM (CAPR)

CUSIP: 14070B101

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
2,433,131
Share change
+1,439,607
Total reported value
$3,842,000
Price per share
$1.58
Number of holders
21
Value change
+$2,078,192
Number of buys
13
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 14070B101?
CUSIP 14070B101 identifies CAPR - CAPRICOR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CAPRICOR THERAPEUTICS INC - COM (CAPR) as of Q4 2017

As of 31 Dec 2017, CAPRICOR THERAPEUTICS INC - COM (CAPR) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,433,131 shares. The largest 10 holders included BROWN ADVISORY INC, Vanguard Group Inc, LLBH Private Wealth Management, LLC, Belpointe Asset Management LLC, GEODE CAPITAL MANAGEMENT, LLC, Apriem Advisors, ACADIAN ASSET MANAGEMENT LLC, NORTHERN TRUST CORP, WELLS FARGO & COMPANY/MN, and Granite Point Capital Management, L.P.. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.